Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis.

Ikeda K, Hamada T, Otsuka M, Iwatsuki K.

Eur J Dermatol. 2011 Sep-Oct;21(5):804-5. doi: 10.1684/ejd.2011.1461. No abstract available.

PMID:
21752760
2.
3.

Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.

Ohno M, Koyama S, Ohara M, Shimamoto K, Kobayashi Y, Nakamura F, Mitsuru K, Andoh A.

Intern Med. 2016;55(1):25-30. doi: 10.2169/internalmedicine.55.5422. Epub 2016 Jan 1.

4.

Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.

Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T.

Ther Apher Dial. 2007 Jun;11(3):177-82.

PMID:
17497998
5.

Generalized pyoderma gangrenosum associated with unrecognized ulcerative colitis.

Giljača V, Lulić D, Ličina M, Stimac D, Cabrijan L, Mijandrušić Sinčić B.

Acta Dermatovenerol Croat. 2014;22(1):63-4. No abstract available.

PMID:
24813846
6.

Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.

Futami H, Kodaira M, Furuta T, Hanai H, Kaneko E.

J Gastroenterol. 1998 Jun;33(3):408-11.

PMID:
9658322
7.

Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.

Kanekura T, Kawahara K, Maruyama I, Kanzaki T.

Ther Apher Dial. 2005 Aug;9(4):292-6.

PMID:
16076369
8.

Pyoderma gangrenosum of the hand: a case series and review of the literature.

Huish SB, de La Paz EM, Ellis PR 3rd, Stern PJ.

J Hand Surg Am. 2001 Jul;26(4):679-85. Review.

PMID:
11466644
9.

[Ulcerative colitis associated with pyoderma gangrenosum].

Tusnádi A, Uhrin K, Bényei M, Krasznai G.

Orv Hetil. 1994 Apr 24;135(17):917-9. Review. Hungarian.

PMID:
7909938
10.

Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report.

Yanaru-Fujisawa R, Matsumoto T, Nakamura S, Kochi S, Iida M, Kohda F, Hirahashi M, Yao T, Mibu R.

Inflamm Bowel Dis. 2005 Aug;11(8):780-1. No abstract available.

PMID:
16043996
11.

A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.

Okuma K, Mitsuishi K, Hasegawa T, Tsuchihashi H, Ogawa H, Ikeda S.

Ther Apher Dial. 2007 Oct;11(5):387-90.

PMID:
17845399
12.

Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.

Russo I, Miotto S, Colpo A, Marson P, Tison T, Ferrazzi A, Alaibac M.

Int Wound J. 2017 Feb;14(1):282-284. doi: 10.1111/iwj.12684. Epub 2016 Oct 28.

PMID:
27790848
13.
14.

Pyoderma gangrenosum and ulcerative colitis in the tropics.

Alese OB, Irabor DO.

Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):664-7.

15.

Therapy Insight: pyoderma gangrenosum-old disease, new management.

Campbell S, Cripps S, Jewell DP.

Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):587-94. Review.

PMID:
16327838
16.

Managing peristomal pyoderma gangrenosum.

Hess CT.

Adv Skin Wound Care. 2001 Nov-Dec;14(6):326-7. No abstract available.

PMID:
11794444
17.

Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.

Al-Niaimi F, Cox NH.

Br J Dermatol. 2009 Nov;161(5):1206-7. doi: 10.1111/j.1365-2133.2009.09426.x. Epub 2009 Aug 12. No abstract available.

PMID:
19678821
18.

Plasma level of granulocyte-colony stimulating factor during granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis.

Takeda H, Nishise S, Fukui T, Fujishima S, Orii T, Otake S, Sato T, Sasaki Y, Kawata S.

Hepatogastroenterology. 2009 Mar-Apr;56(90):348-51.

PMID:
19579596
19.
20.

Pyoderma gangrenosum: uncommon presentations.

Ahmadi S, Powell FC.

Clin Dermatol. 2005 Nov-Dec;23(6):612-20. Review.

PMID:
16325070

Supplemental Content

Support Center